Sara Ramezani
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Sara Ramezani has a total of 70 co-authors. Here are the top co-authors by number of shared publications:
Babak Bakhshayesh Eghbali
Neuroscience Research Center, Trauma Institute Guilan University of Medical Sciences Rasht Iran
4 shared publicationsNaser Amini
Cellular and Molecular Research Centre, Iran University of Medical Sciences, Tehran, Iran
4 shared publicationsZoheir Reihanian
Department of Neurosurgery, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran
4 shared publicationsCyrus Emir Alavi
Neuroscience Research Center, Trauma Institute Guilan University of Medical Sciences Rasht Iran
3 shared publications- Shahrokh Yousefzadeh-Chabok
Guilan Road Trauma Research Center, Trauma Institute, Guilan University of Medical Sciences, Rasht, Iran
3 shared publications Sina Sedaghat Herfeh
Neuroscience Research Center, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran
3 shared publications
Latest Publications
- 18 November 2025
- Published by Wiley in Pain Practice
- Vol. 26 (1) , e70092
Immediate and Long‐Term Effects of Different Montages of Transcranial Direct Current Stimulation Over Primary Visual Cortex in Patients With Chronic Migraine: A Randomized, Double‐Blind, Sham‐Controlled Trial
Background: We evaluated the immediate and long‐term therapeutic efficacy of transcranial direct current stimulation (tDCS) using two distinct montages of anodal and cathodal electrical stimulation over the primary visual cortex compared with a sham tDCS in patients with chronic migraines. Methods: In this randomized, double‐blind, controlled trial, 72 eligible patients with resistant chronic migraine were randomly assigned to one of three groups, receiving anodal or cathodal (2 mA for 20 min), or sham tDCS (0.5 mA for 30 s), over the pain‐dominant side of the primary visual cortex. Clinical features including the number of migraine attacks per month, attack duration, pain intensity, and frequency of painkiller use at baseline, 2 months after starting and ending tDCS therapy were recorded using a personal questionnaire. Results: Both anodal and cathodal real tDCS protocols resulted in a significant reduction in the number of attacks, pain intensity, attack duration, and frequency of painkiller use during the treatment period compared to baseline. There was no significant difference between the two treatment groups regarding the therapeutic efficacy. However, only anodal tDCS significantly maintained the beneficial therapeutic effects on the number of migraine attacks and painkiller use at the follow‐up phase. The sham protocol did not produce any significant clinical utility in this population. Conclusions: The study supports the analgesic effects of the proposed real tDCS approaches in patients with resistant chronic migraine. Anodal tDCS may offer superior benefits to cathodal tDCS, likely by stabilizing therapeutic outcomes through reorganizing the thalamocortical pathway.
- 18 November 2025
- Published by Wiley in Pain Practice
- Vol. 26 (1) , e70092
Immediate and Long‐Term Effects of Different Montages of Transcranial Direct Current Stimulation Over Primary Visual Cortex in Patients With Chronic Migraine: A Randomized, Double‐Blind, Sham‐Controlled Trial
Background: We evaluated the immediate and long‐term therapeutic efficacy of transcranial direct current stimulation (tDCS) using two distinct montages of anodal and cathodal electrical stimulation over the primary visual cortex compared with a sham tDCS in patients with chronic migraines. Methods: In this randomized, double‐blind, controlled trial, 72 eligible patients with resistant chronic migraine were randomly assigned to one of three groups, receiving anodal or cathodal (2 mA for 20 min), or sham tDCS (0.5 mA for 30 s), over the pain‐dominant side of the primary visual cortex. Clinical features including the number of migraine attacks per month, attack duration, pain intensity, and frequency of painkiller use at baseline, 2 months after starting and ending tDCS therapy were recorded using a personal questionnaire. Results: Both anodal and cathodal real tDCS protocols resulted in a significant reduction in the number of attacks, pain intensity, attack duration, and frequency of painkiller use during the treatment period compared to baseline. There was no significant difference between the two treatment groups regarding the therapeutic efficacy. However, only anodal tDCS significantly maintained the beneficial therapeutic effects on the number of migraine attacks and painkiller use at the follow‐up phase. The sham protocol did not produce any significant clinical utility in this population. Conclusions: The study supports the analgesic effects of the proposed real tDCS approaches in patients with resistant chronic migraine. Anodal tDCS may offer superior benefits to cathodal tDCS, likely by stabilizing therapeutic outcomes through reorganizing the thalamocortical pathway.
- 28 November 2024
- Published by Wolters Kluwer Health in American Journal of Physical Medicine & Rehabilitation
- Vol. 104 (6) , 551-557
Bihemispheric Transcranial Direct Current Stimulation Over Primary Motor Cortex Potentiates Improvement of Neurological but not Upper Limb Motor Functions in Ischemic Stroke Patients Treated With Routine Physical Therapy
Objectives: We investigated the therapeutic effect of transcranial direct current stimulation combined with routine physiotherapy on the neurological and upper limb motor function in ischemic stroke patients with hemiplegia. Methods: In a randomized double-blind controlled trial study, 52 eligible stroke patients were assigned to real transcranial direct current stimulation receiving bihemispheric electrical current with 1.5 mA for 30 mins over the primary motor cortex, and sham transcranial direct current stimulation with a current intensity of 0.5 mA for 30 secs. Both groups received routine physiotherapy, 5 sessions per week for 2 wks. The National Institute of Health Stroke Scale and the Medical Research Council Scale for Muscle Strength were used to assess the neurological and upper limb motor functions, respectively. Results: Both therapeutic approaches begot a significant improvement in upper limb motor function and neurological impairment at the last session of therapy and follow-up study. However, the treatment-induced neurological amelioration at the last session of therapy in real transcranial direct current stimulation was significantly more than sham, especially in those identified as female and under 60 yrs old. Conclusions: A gender and age-specific protocol of real transcranial direct current stimulation combined with routine physiotherapy might be beneficial to improve neurological impairment but not upper limb motor dysfunction after stroke.
- 28 November 2024
- Published by Wolters Kluwer Health in American Journal of Physical Medicine & Rehabilitation
- Vol. 104 (6) , 551-557
Bihemispheric Transcranial Direct Current Stimulation Over Primary Motor Cortex Potentiates Improvement of Neurological but not Upper Limb Motor Functions in Ischemic Stroke Patients Treated With Routine Physical Therapy
Objectives: We investigated the therapeutic effect of transcranial direct current stimulation combined with routine physiotherapy on the neurological and upper limb motor function in ischemic stroke patients with hemiplegia. Methods: In a randomized double-blind controlled trial study, 52 eligible stroke patients were assigned to real transcranial direct current stimulation receiving bihemispheric electrical current with 1.5 mA for 30 mins over the primary motor cortex, and sham transcranial direct current stimulation with a current intensity of 0.5 mA for 30 secs. Both groups received routine physiotherapy, 5 sessions per week for 2 wks. The National Institute of Health Stroke Scale and the Medical Research Council Scale for Muscle Strength were used to assess the neurological and upper limb motor functions, respectively. Results: Both therapeutic approaches begot a significant improvement in upper limb motor function and neurological impairment at the last session of therapy and follow-up study. However, the treatment-induced neurological amelioration at the last session of therapy in real transcranial direct current stimulation was significantly more than sham, especially in those identified as female and under 60 yrs old. Conclusions: A gender and age-specific protocol of real transcranial direct current stimulation combined with routine physiotherapy might be beneficial to improve neurological impairment but not upper limb motor dysfunction after stroke.
- 28 August 2023
- Published by Elsevier in Psychiatry Research: Neuroimaging
- Vol. 335, 111709
Role of brain metabolites during acute phase of mild traumatic brain injury in prognosis of post-concussion syndrome: A 1H-MRS study
- 28 August 2023
- Published by Elsevier in Psychiatry Research: Neuroimaging
- Vol. 335, 111709
Role of brain metabolites during acute phase of mild traumatic brain injury in prognosis of post-concussion syndrome: A 1H-MRS study
- 21 November 2022
- Published by Taylor & Francis in Brain Injury
- Vol. 37 (1) , 63-73
¬Transcranial direct current stimulation improves sleep quality in patients with insomnia after traumatic brain injury
Insomnia is a serious problem after traumatic brain injury (TBI) and partially improves via sleeping pills. We investigated the efficacy of transcranial direct current stimulation (tDCS) with a foc...
- 21 November 2022
- Published by Taylor & Francis in Brain Injury
- Vol. 37 (1) , 63-73
¬Transcranial direct current stimulation improves sleep quality in patients with insomnia after traumatic brain injury
Insomnia is a serious problem after traumatic brain injury (TBI) and partially improves via sleeping pills. We investigated the efficacy of transcranial direct current stimulation (tDCS) with a foc...
- 6 October 2022
- Published by Wiley in American Journal of Human Biology
- Vol. 34 (12) , e23810
The association of 25 (OH) D3 serum level with ischemic cerebrovascular accident risk, severity and outcome in Iranian population
Objectives: The role of combined presence of vitamin D deficiency and other risk factors of stroke in ischemic cerebrovascular accident (CVA) development in Iranian adults has been unclear, so far. The association of vitamin D status at admission with ischemic CVA severity and outcome in this community is not yet well elucidated. This study aimed to clarify these ambiguities.Methods: In a cross‐sectional study 104 hospitalized ischemic CVA patients and 104 healthy controls participated. The serum level of 25 (OH) D3 and baseline biochemical parameters were measured in ischemic patients within the first 24 h of admission, as well as healthy controls. The severity of CVA and clinical outcome were assessed using National Institutes Health Stroke Scale and Modified Rankin Scale, respectively. Data were analyzed using the Chi‐square test, independent t‐test, and multiple logistic regression.Results: There was a significant difference between patients and controls regarding the presence of vitamin D3 deficiency, hypertension, smoking, and baseline level of LDL and FBS. Vitamin D3 deficiency boosted the risk of ischemic in males and those having family history of CVA. A low serum level of 25 (OH) D3 was associated with more severity and poor outcome of CVA. The CVA severity, vitamin D3 deficiency, and hypertension were predictors of poor outcome.Conclusions: The study highlights the increased risk of ischemia in Iranians by cooccurrence of vitamin D3 deficiency and other risk factors of CVA. Clinical significance of vitamin D3 deficiency control may be suggested in those at risk of CVA and functional poor outcomes.
- 6 October 2022
- Published by Wiley in American Journal of Human Biology
- Vol. 34 (12) , e23810
The association of 25 (OH) D3 serum level with ischemic cerebrovascular accident risk, severity and outcome in Iranian population
Objectives: The role of combined presence of vitamin D deficiency and other risk factors of stroke in ischemic cerebrovascular accident (CVA) development in Iranian adults has been unclear, so far. The association of vitamin D status at admission with ischemic CVA severity and outcome in this community is not yet well elucidated. This study aimed to clarify these ambiguities.Methods: In a cross‐sectional study 104 hospitalized ischemic CVA patients and 104 healthy controls participated. The serum level of 25 (OH) D3 and baseline biochemical parameters were measured in ischemic patients within the first 24 h of admission, as well as healthy controls. The severity of CVA and clinical outcome were assessed using National Institutes Health Stroke Scale and Modified Rankin Scale, respectively. Data were analyzed using the Chi‐square test, independent t‐test, and multiple logistic regression.Results: There was a significant difference between patients and controls regarding the presence of vitamin D3 deficiency, hypertension, smoking, and baseline level of LDL and FBS. Vitamin D3 deficiency boosted the risk of ischemic in males and those having family history of CVA. A low serum level of 25 (OH) D3 was associated with more severity and poor outcome of CVA. The CVA severity, vitamin D3 deficiency, and hypertension were predictors of poor outcome.Conclusions: The study highlights the increased risk of ischemia in Iranians by cooccurrence of vitamin D3 deficiency and other risk factors of CVA. Clinical significance of vitamin D3 deficiency control may be suggested in those at risk of CVA and functional poor outcomes.
- Open Access
- 30 June 2022
- Published by CMV Verlag in Journal of Current Biomedical Reports
- Vol. 3 (2) , 77-83
The characterization of oxaliplatin-induced peripheral neuropathy using electromyography in gastrointestinal cancer patients
Oxaliplatin-induced peripheral neuropathy (OIPN) is a common dose-dependent chemotherapy complication in gastrointestinal cancer (GIC). This side effect may restrict therapeutic dose elevation of oxaliplatin. Here, OIPN frequency and determinants of neuropathy appearance in oxaliplatin-treated GIC patients. A total of 102 GIC patients who underwent chemotherapy with fluorouracil, folinic acid and oxaliplatin (FOLFOX4) regimen participated in this longitudinal study. Electromyography (EMG) was accomplished for ulnar, radial, sural, peroneal nerves and superficial peroneal nerve (SPN) before, 3, and 6 months after treatment. National Cancer Institute-Common Toxicity Criteria V.3 and clinical version of the Total Neuropathy Score were used for the neuropathy diagnosis at six months after treatment onset. Of all entered patients, twelve people discontinued this study, and five patients passed away. About 85 patients remained three and six months after chemotherapy onset. Approximately 95% of patients three months after chemotherapy demonstrated OIPN manifestations. Finally, data for 81 patients having neuropathy were analyzed. Mean age of patient 64.0±10.9 years. There were about 3.7%, 30.9%, 63% grade III, II, I of neuropathy, respectively. Interestingly, a significant decrease in action potential (AP) amplitude of SPN, sural and radial nerves but not ulnar and peroneal was observed after treatment onset. However, only the ulnar nerve indicated a substantial deceleration of nerve conduction. Age, sex, weight, past medical diseases, smoking and acute neuropathy were not significantly associated with OIPN. The occurrence of OIPN is detectable by electrophysiological changes of SPN, radial, and sural nerves at three and six months after starting chemotherapy with the FOLFOX4 regimen.
- 30 June 2022
- Published by CMV Verlag in Journal of Current Biomedical Reports
- Vol. 3 (2) , 77-83
Open AccessThe characterization of oxaliplatin-induced peripheral neuropathy using electromyography in gastrointestinal cancer patients
Oxaliplatin-induced peripheral neuropathy (OIPN) is a common dose-dependent chemotherapy complication in gastrointestinal cancer (GIC). This side effect may restrict therapeutic dose elevation of oxaliplatin. Here, OIPN frequency and determinants of neuropathy appearance in oxaliplatin-treated GIC patients. A total of 102 GIC patients who underwent chemotherapy with fluorouracil, folinic acid and oxaliplatin (FOLFOX4) regimen participated in this longitudinal study. Electromyography (EMG) was accomplished for ulnar, radial, sural, peroneal nerves and superficial peroneal nerve (SPN) before, 3, and 6 months after treatment. National Cancer Institute-Common Toxicity Criteria V.3 and clinical version of the Total Neuropathy Score were used for the neuropathy diagnosis at six months after treatment onset. Of all entered patients, twelve people discontinued this study, and five patients passed away. About 85 patients remained three and six months after chemotherapy onset. Approximately 95% of patients three months after chemotherapy demonstrated OIPN manifestations. Finally, data for 81 patients having neuropathy were analyzed. Mean age of patient 64.0±10.9 years. There were about 3.7%, 30.9%, 63% grade III, II, I of neuropathy, respectively. Interestingly, a significant decrease in action potential (AP) amplitude of SPN, sural and radial nerves but not ulnar and peroneal was observed after treatment onset. However, only the ulnar nerve indicated a substantial deceleration of nerve conduction. Age, sex, weight, past medical diseases, smoking and acute neuropathy were not significantly associated with OIPN. The occurrence of OIPN is detectable by electrophysiological changes of SPN, radial, and sural nerves at three and six months after starting chemotherapy with the FOLFOX4 regimen.
- 1 November 2021
- Published by Elsevier in Brain Research
- Vol. 1770, 147624
Animal Kernicterus Models: Progress and Challenges
- 1 November 2021
- Published by Elsevier in Brain Research
- Vol. 1770, 147624
Animal Kernicterus Models: Progress and Challenges
- 1 July 2020
- Published by Negah Scientific Publisher in Iranian Journal of Neurosurgery
- Vol. 5 (3) , 109-116
The Role of Dietitian in Improving Energy and Protein Intake in Traumatic Brain Injury Patients Admitted to the Neurosurgical Intensive Care Unit
Introduction:Early and sufficient nutritional support is vital to improve outcomes in patients with traumatic brain injury. This study aims to determine the effects of dietitian involvementin the nutritional and clinical outcomes inpatients with traumatic brain injuries admitted tothe neurosurgical ICU. Materials &Methods: Forty-eight male patients with traumatic brain injuries admitted to Poursina Hospital neurosurgical ICU were studied, retrospectively. Patients were divided to either receive dietitian intervention or without any nutritional recommendation(control). Demographic information, Glasgow Coma Scale and Acute Physiology and Chronic Health Evaluation II (APACHE II) scores, the timing of initial enteral feeding, the amount of energy and protein intakeon day 4, the duration of mechanical ventilation and ICU length of stay were recorded. Results:Patients under the dietitian recommendation had significantly lower timing of initial enteral nutrition compared to the other cases (P=0.02). The average energy or protein intake and the percentage of target energy or protein intake on day4 appeared to be significantly lower in the subjects in the control group than in those with nutritional intervention(P≤0.001). There was no statistically significant difference in the duration of mechanical ventilation and ICU length of staybetween different groups of patients. Conclusions:Instead of occasional consultations for exclusive cases, the daily attendance of dietitians during multidisciplinary rounds of ICU is required to assess the nutritional needs of patients.
- 1 July 2020
- Published by Negah Scientific Publisher in Iranian Journal of Neurosurgery
- Vol. 5 (3) , 109-116
The Role of Dietitian in Improving Energy and Protein Intake in Traumatic Brain Injury Patients Admitted to the Neurosurgical Intensive Care Unit
Introduction:Early and sufficient nutritional support is vital to improve outcomes in patients with traumatic brain injury. This study aims to determine the effects of dietitian involvementin the nutritional and clinical outcomes inpatients with traumatic brain injuries admitted tothe neurosurgical ICU. Materials &Methods: Forty-eight male patients with traumatic brain injuries admitted to Poursina Hospital neurosurgical ICU were studied, retrospectively. Patients were divided to either receive dietitian intervention or without any nutritional recommendation(control). Demographic information, Glasgow Coma Scale and Acute Physiology and Chronic Health Evaluation II (APACHE II) scores, the timing of initial enteral feeding, the amount of energy and protein intakeon day 4, the duration of mechanical ventilation and ICU length of stay were recorded. Results:Patients under the dietitian recommendation had significantly lower timing of initial enteral nutrition compared to the other cases (P=0.02). The average energy or protein intake and the percentage of target energy or protein intake on day4 appeared to be significantly lower in the subjects in the control group than in those with nutritional intervention(P≤0.001). There was no statistically significant difference in the duration of mechanical ventilation and ICU length of staybetween different groups of patients. Conclusions:Instead of occasional consultations for exclusive cases, the daily attendance of dietitians during multidisciplinary rounds of ICU is required to assess the nutritional needs of patients.
- 1 April 2020
- Published by Negah Scientific Publisher in Iranian Journal of Neurosurgery
- Vol. 6 (2) , 73-82
Hemorrhages Seen on Brain Images After Mild Traumatic Brain Injury May Increase the Risk of Post-concussion Syndrome
Background and Aim: Mild Traumatic Brain Injury (mTBI) mostly develops the symptoms that may persist for over three months known as Post-Concussion Syndrome (PCS). However, the PCS potential risk for mTBI victims is not well-identified. Here, we investigated the putative risk factors of PCS. Methods and Materials/Patients: In a cross-sectional study, we collected (HIS) the demographic, clinical, and radiological data using the hospital information system in 388 mTBI patients who passed at least 3 months since the onset of their injury and referred to Poursina hospital from March 2017 to December 2018. The patients were examined to diagnose PCS by a general physician using the phone interview via the Rivermead Post-concussion Symptoms Questionnaire (RPQ). The subjects were separated into groups with and without PCS. Data were analyzed by parametric t-test, Chi-square test and multiple logistic regression. Results: One-hundred ninety one out of 388 mTBI patients consented to complete the RPQ and around 59% of cases experienced PCS. There was no significant difference in the demographic variables and past medical history between groups. However, the previous psychological disease was particularly associated with PCS (P>0.043). Length of hospitalization, functional outcome during discharge, and post-resuscitation consciousness did not show any significant association with PCS (P<0.05). Interestingly, initial abnormal brain scan, fronto-temporal lesion, and accompanied hematoma (hemorrhages) were identified as risk factors of mTBI-induced PCS. The risk of PCS was found to increase by 7.2 times in mTBI patients demonstrated as an abnormality in their initial brain scans (P<0.001). A directly proportional relationship was found between the occurrence of the syndrome and the fronto-temporal lesion (P<0.017). Accompanied hematoma enhanced the risk of PCS by 2.6 times (P<0.04). Conclusion: This study emphasized the significance of early brain scan data for the prediction of PCS and the necessity of proper follow-up care for the at-risk population. The reported data from this study might be applied as an objective trajectory to measure PCS in those who simulated PCS for the litigation.
- 1 April 2020
- Published by Negah Scientific Publisher in Iranian Journal of Neurosurgery
- Vol. 6 (2) , 73-82
Hemorrhages Seen on Brain Images After Mild Traumatic Brain Injury May Increase the Risk of Post-concussion Syndrome
Background and Aim: Mild Traumatic Brain Injury (mTBI) mostly develops the symptoms that may persist for over three months known as Post-Concussion Syndrome (PCS). However, the PCS potential risk for mTBI victims is not well-identified. Here, we investigated the putative risk factors of PCS. Methods and Materials/Patients: In a cross-sectional study, we collected (HIS) the demographic, clinical, and radiological data using the hospital information system in 388 mTBI patients who passed at least 3 months since the onset of their injury and referred to Poursina hospital from March 2017 to December 2018. The patients were examined to diagnose PCS by a general physician using the phone interview via the Rivermead Post-concussion Symptoms Questionnaire (RPQ). The subjects were separated into groups with and without PCS. Data were analyzed by parametric t-test, Chi-square test and multiple logistic regression. Results: One-hundred ninety one out of 388 mTBI patients consented to complete the RPQ and around 59% of cases experienced PCS. There was no significant difference in the demographic variables and past medical history between groups. However, the previous psychological disease was particularly associated with PCS (P>0.043). Length of hospitalization, functional outcome during discharge, and post-resuscitation consciousness did not show any significant association with PCS (P<0.05). Interestingly, initial abnormal brain scan, fronto-temporal lesion, and accompanied hematoma (hemorrhages) were identified as risk factors of mTBI-induced PCS. The risk of PCS was found to increase by 7.2 times in mTBI patients demonstrated as an abnormality in their initial brain scans (P<0.001). A directly proportional relationship was found between the occurrence of the syndrome and the fronto-temporal lesion (P<0.017). Accompanied hematoma enhanced the risk of PCS by 2.6 times (P<0.04). Conclusion: This study emphasized the significance of early brain scan data for the prediction of PCS and the necessity of proper follow-up care for the at-risk population. The reported data from this study might be applied as an objective trajectory to measure PCS in those who simulated PCS for the litigation.
- 31 October 2019
- Published by Springer Nature in European Journal of Trauma and Emergency Surgery
- Vol. 47 (3) , 839-846
Determinants of long-term health-related quality of life in adult patients with mild traumatic brain injury
Mild traumatic brain injury (mTBI) usually leads to the appearance of post-concussion symptoms (PCS) which may resolve after a short time. In this study, the mental and physical aspects of quality of life (QoL) were evaluated 6 months after mTBI, and the association of demographic and injury-related factors, post-injury primary executive function and PCS types with the long-term QoL status was investigated.
- 31 October 2019
- Published by Springer Nature in European Journal of Trauma and Emergency Surgery
- Vol. 47 (3) , 839-846
Determinants of long-term health-related quality of life in adult patients with mild traumatic brain injury
Mild traumatic brain injury (mTBI) usually leads to the appearance of post-concussion symptoms (PCS) which may resolve after a short time. In this study, the mental and physical aspects of quality of life (QoL) were evaluated 6 months after mTBI, and the association of demographic and injury-related factors, post-injury primary executive function and PCS types with the long-term QoL status was investigated.